FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1208686000: Product containing alogliptin and pioglitazone (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4970507013 Product containing alogliptin and pioglitazone (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4970508015 Alogliptin- and pioglitazone-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4970507013 Product containing alogliptin and pioglitazone (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4970508015 Alogliptin- and pioglitazone-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


9 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing alogliptin and pioglitazone (medicinal product) Is a Product containing pioglitazone (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alogliptin and pioglitazone (medicinal product) Is a Product containing alogliptin (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alogliptin and pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pioglitazone (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing alogliptin and pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Alogliptin true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Alogliptin and pioglitazone only product Is a True Product containing alogliptin and pioglitazone (medicinal product) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alogliptin and pioglitazone in oral dose form (medicinal product form) Is a True Product containing alogliptin and pioglitazone (medicinal product) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start